General Stocks

The world's leading economy saw its shares opening in green ahead of the Fed's Beige Book; a survey on Current Economic Conditions, although worries remain spread regarding the present stagnated recovery of the country having the Bank of America Corp was the most active U.S. stock while other actively traded shares include Citigroup Inc; Amylin Pharmaceuticals Inc; Alkermes Inc; and Wells Fargo & Co. The U.S. Dollar index, which measures the green Benjamin's performance versus six major currencies, declined to currently trade at 81.20 recording a high of 78.35 and a low 77.37, while gold is inclining faintly on the daily base to trade around $1335.76 an ounce and the black gold for instance plunged slightly to trade around $80.61 a barrel. The best performing sectors within the Dow were the Basic Materials next to Telecommunications and Consumer Services shares, The S&P 500's best performing sectors were the Basic Materials, Telecommunications and Utilities shares, the NASDAQ Composite index best performing sectors were...

Asian stocks witnessed mixed performances as technology shares witnessed fluctuations following Apple’s disappointing third quarter results. On the other hand, Australia's central bank announced today the minutes of their meeting in which they held rates unchanged, which appears to be appropriate for the current economic conditions, giving support to the Australian shares. The MSCI Asia Pacific Index fell today by 0.2% to 130.11 at 13:40 in Tokyo, while the yen fell against the dollar, giving support to the Japanese exporting companies’ shares. Nikkei 225 Nikkei 225 rose today by 0.43% or 40.96 points closing at 9593.45. From 225 shares, 154 advanced, 57 declined and 14 unchanged. Sectors leading the incline were the industrials that gained 12.32 points, consumer goods that gained 11.24 points and health care that gained 8.00 points. Among the shares that advanced Fanuc Ltd topped the list by rising 1.78% closing at 11420 yen, followed by KDDI Corp which rose by 3.13% and closing at 411500 yen. And Terumo Corp which...

Mixed data and speculations the Feds will not provide more stimulus plans to improve recovery and sustain the jobs sector pushed the MSCI Asia Pacific Index down today by 0.6% to 130.31 at 16:00 in Tokyo, as investors lost their appetite for risk, moving to lower yielding assets like the dollar and the yen. Nikkei 225 Nikkei 225 fell today by 0.02% or 1.76 points closing at 9498.49. From 225 shares, 118 advanced, 90 declined and 17 unchanged. Sectors leading the decline were the industrials that lost 12.08 points, the telecommunications that lost 4.33 points and consumer services that lost 2.79 points. Lagging shares today Fast Retailing Co Ltd which fell by 2.13% closing at 10590 yen, second was Softbank Corp which fell by 1.42% closing at 2709 yen. Third was Fanuc Ltd which fell by 0.80% and closed at 11220 yen. Among the shares that advanced Honda Motor Co Ltd topped the list by rising 1.01% closing at 2994 yen, followed by NGK...

Investors lost their appetite for risk, looking for safer assets, on fears over the strength of the largest economy in the world based on poor economic data from the jobs sector. The MSCI Asia Pacific Index fell from a two years high by 0.6% to 131.27 at 15:08 in Tokyo. Nikkei 225 Nikkei 225 fell today by 0.87% or 83.26 points closing at 9500.25. From 225 shares, 29 advanced, 183 declined and 13 unchanged. Sectors leading the decline were consumer goods that lost 20.89 points, the industrials that lost 18.91 points and the financials that lost 15.51 points. Lagging shares today Fast Retailing Co Ltd which fell by 1.46% closing at 10820 yen, second was NTT Data Corp which fell by 3.35% closing at 245400 yen. Third was Honda Motor Co Ltd which fell by 1.36% and closed at 2964 yen. Among the shares that advanced Tokyo Electron Ltd topped the list by rising 2.47% closing at 4765 yen, followed by Fanuc Ltd which...

By Toni Clarke and Bill Berkrot NEW YORK (Reuters) - Genzyme Corp made its case for why it is worth more than Sanofi-Aventis's $18.5 billion offer, forecasting 2011 profit above Wall Street estimates and sales of $3 billion for its experimental multiple sclerosis drug. Genzyme's presentation in New York on Friday kicks off a series of meetings with investors over the next few weeks and shows how far apart the two companies are on a potential deal. Genzyme <GENZ.O> executives said their earnings forecast implied a price as high as $89 per share, based on the multiple underlying Sanofi's <SASY.PA> hostile $69 per share offer. But they stressed that $89 was not a negotiating price, merely a benchmark based on Genzyme's earnings forecast. A Sanofi spokesman called $89 per share "totally unrealistic." Shares in Genzyme rose 0.7 percent to $72.45 after the presentation, suggesting that investors believe it had raised the threshold on what Sanofi must ultimately pay. Genzyme investors and analysts polled by Reuters...

SYDNEY (Reuters) - Rio Tinto chief executive Tom Albanese said ongoing tensions with Canadian partner Ivanhoe Mines would not hold back the Oyu Tolgoi copper and gold project in Mongolia which he said could be brought on stream early. Albanese said in a television interview broadcast on Sunday he hoped to see first production from the mine in 2013, and said both Rio Tinto and Ivanhoe Mines were committed to its rapid development despite their disagreements. "It's very important for Rio Tinto. It's very important for Ivanhoe. It's also very important for Mongolia. It's a first class mine being built on time," Albanese told the Australian Broadcasting Corporation (ABC) programme Inside Business. "I'd like to actually see it get sped up if we can, first production by 2013. It is on track as we speak." Last week Ivanhoe Mines said it would launch a rights offering worth up to $1 billion to raise funds for the project, which finally got the go-ahead from the...